Catalog Number UNK-HIP |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Host-Tissue Reaction (1297); Abscess (1690); Cyst(s) (1800); Edema (1820); Fever (1858); Foreign Body Reaction (1868); Unspecified Infection (1930); Pain (1994); Discomfort (2330); Osteolysis (2377); No Code Available (3191)
|
Event Date 04/29/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
This complaint is still under investigation.Depuy will notify the fda of the results of this investigation once it has been completed.Udi: unavailable if information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
The patient was revised to address pain.
|
|
Manufacturer Narrative
|
No device associated with this report was received for examination.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4) used to capture the medical device removal.
|
|
Event Description
|
Asr litigation records received alleging injury, economic loss, pain, discomfort, mental and emotional pain, anguish, suffering and multiple surgeries.Doi: (b)(6) 2006 - dor: (b)(6) 2014 (left hip).
|
|
Event Description
|
After review of medical records, the patient was partially revised due to pseudotumor secondary to mom articulation, metallosis and suspected infection.Patient also had elevated white counts, fever, increased pain, mri suspicious for abscess formation and influenza.Operative note reported edema within subcutaneous layer.On the trochanteric bursa, there was a gray stained bursal tissue, consistent with pseudotumor and some purulent material and osteolytic cyst.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.(b)(4).
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|